Please Note - Streaming News is only available to subscribers to the Active Level and above
CORRECT: AstraZeneca asthma drug okayed in EU for self-administration
ALN
(Correcting headline to refer to EU.)
AstraZeneca PLC on Friday said Tezspire has been approved for self-administration in the EU in a new pre-filled pen, for severe asthma patients aged 12 years and older.
The Cambridge-based pharmaceutical company said Tezspire, whose generic name is tezepelumab, received a positive opinion from the European Medicine Agency‘
